Chloramphenicol

Chloramphenicol

Content

Chloramphenicol

       Mechanism
of action

       Pharmacokinetics

       Drug
interactions

       Adverse
effects

       Clinical
uses

Objectives

At the end of this session, students will be able to:

       Describe
the mechanism of action of Chloramphenicol

       Outline
the pharmacokinetics of Chloramphenicol

       Explain
the drug interactions and clinical uses of Chloramphenicol

Chloramphenicol

       Broad
spectrum antibiotic

       Isolated
from Streptomyces venezuelae

       Contains
nitro group as nitrobenzene moiety

Mechanism of action

       Inhibits bacterial protein synthesis

       Binds 50S subunit and block
elongation

       Inhibits the formation of initiation
complexes and peptidyltransferase;

       Binding site overlaps with that of
macrolides and clindamycin

       Primarily bacteriostatic

       May be bactericidal to some strains
of microorganisms even at lower concentration

Binding site of chloramphenicol

Mechanism of resistance

       Selection of permeability mutants

       Results in impaired penetration of
the drug to target site

       Production of chloramphenicol acetyltransferase,
a plasmid-encoded enzyme that inactivates the drug

Antimicrobial spectrum

       active against a broad range of
organisms, including G+ and G-bacteria (including anaerobes)

       Effects on G- bacteria is better
than on G+ bacteria, especially Salmonella typhi

       At low concentration effective
against H. influenzae, N. meningitidis and N. gonorrhoeae

Pharmacokinetics

       Administration
in crystalline form

       Parenteral
– Chloramphenicol sodium succinate

       Oral
– Chloramphenicol palmitate

       Oral  – rapid and complete absorption

       Widely
distributed

       Metabolized
by glucuronyl transferase and aryl amide

       30-60%
protein bound

       Secreted
in breast milk

       75-90%
excreted in inactive form through kidneys

       Small
amount in bile

Adverse effects

Bone
marrow Disturbance

       Reversible bone marrow depression

       Chloramphenicol inhibits protein
synthesis in the mitochondria of human cells

       Dose dependent toxicity of drug to
bone marrow

Toxicity
for Newborn Infants (Gray-baby syndrome)

       In neonates, especially premature
infants

       Given relatively large doses of
chloramphenicol

       Cyanosis, respiratory irregularities

       Abdominal distention, loose green
stool, and an ashen-gray color

       Gastrointestinal reaction. nausea,
vomiting, diarrhea

        Super infections such as Oropharyngeal
candidiasis and acute Staphylococcal enterocolitis

       Hypersensitivity reactions

       A rare anaemia, probably
immunological in origin but often fatal

Drug interactions

       Paracetamol
increases the bioavailbility of chloramphenicol

       Cloramphenicol
  enzyme inhibitor

       Inhibits
the metabolism of morphine, chlorpropamide and warfarin

Clinical uses

       Meningitis

       Typhoid
fever

       Sepsis
caused by gram negative organisms

       Bacterial
fragilis

       Rickettsial
disease

       Topically
used for eye and ear infection

Summary

       Chloramphenicol
is a broad spectrum antibiotic isolated from Streptomyces venezuelae and
it contains nitro group as nitrobenzene moiety

       Binds 50S subunit, block elongation
and inhibits the formation of initiation complexes by inhibiting
peptidyltransferase

       Used
for the treatment of bacterial fragilis, meningitis, Typhoid fever

       Associated
with sever adverse effects like gray baby’s syndrome and bone marrow depression

 

 

For PDF Notes Click on Download Button

For PPT Notes Click on Download Button

Leave a Comment